Experimental systemic virulence of oral Candida dubliniensis isolates in comparison with Candida albicans, Candida tropicalis and Candida krusei

Mycoses

Volumn 54, Issue 5, 2011, Pages

  Koga Ito, Cristiane Yumi ^a   Komiyama, Edson Yukio ^a   de Paiva Martins, Clélia Aparecida ^a   Vasconcellos, Thássia Castro ^a   Cardoso Jorge, Antonio Olavo ^a   Carvalho, Yasmin Rodarte ^a   do Prado, Renata Falchete ^a   Balducci, Ivan ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Candida dubliniensis; Candida spp; Pathogenicity; Virulence

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA KRUSEI; CANDIDA TROPICALIS; CANDIDIASIS; FUNGAL COLONIZATION; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS ISOLATION; HISTOPATHOLOGY; KIDNEY; KIDNEY INJURY; LIVER; LUNG; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPECIES COMPARISON; SPLEEN; SURVIVAL RATE;

ANIMAL STRUCTURES; ANIMALS; CANDIDA; CANDIDEMIA; CANDIDIASIS, ORAL; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; RODENT DISEASES; SURVIVAL ANALYSIS; VIRULENCE;

ANIMALIA; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA TROPICALIS; ISSATCHENKIA ORIENTALIS; MUS;

EID: 80052813279     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2010.01899.x     Document Type: Article

References (22)

1. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunossupressed patients. Lancet Infect Dis 2003; 3: 658-720.
2. Sant'ana PL, Milan EP, Martinez R et al. Multicenter Brazilian Study of oral Candida species isolated from AIDS patients. Mem Inst Oswaldo Cruz 2002; 97: 253-7.
3. Coleman DC, Sullivan DJ, Bennet DE, Moran GP, Barry HJ, Shanley DB. Candidiasis: the emergence of a novel species: Candida dubliniensis. AIDS 1997; 11: 557-67.
4. Kirkpatrick WR, Lopes-Ribot JL, Mcatee RK, Patterson TF. Growth competition between Candida dubliniensis and Candida albicans under broth and biofilm growing conditions. J Clin Microbiol 2000; 38: 902-4.
5. Sullivan DJ, Moran GP, Pinjón E et al. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res 2004; 4: 369-76.
6. Stokes C, Moran GP, Spiering MJ, Cole GT, Coleman DC, Sullivan DJ. Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans. Fungal Genet Biol 2007; 44: 920-31.
7. Asmundsdóttir LR, Erlendsdóttir H, Haraldsson G, Guo H, Xu J, Gottfredson M. Molecular epidemiology of candidemia: evidence of clusters of smoldering nosocomial infections. Clin Infect Dis 2008; 47: e17-e24.
8. Chan T. Fatal Candida dubliniensis septicemia in a patient with AIDS. Clin Infect Dis 2005; 40: 1209-10.
9. Jabra-Rizk MA, Johnson JK, Forrest G, Mankes K, Meiller TF, Venezia RA. Prevalence of Candida dubliniensis fungemia at a large teaching hospital. Clin Infect Dis 2005; 41: 1064-7.
10. Metwally L, Walker MJ, Coyle PV et al. Trends in candidemia and antifungal susceptibility in a university hospital in Northern Ireland 2001-2006. J Infect 2007; 55: 174-8.
11. Mubareka S, Vinh DC, Sanche SE. Candida dubliniensis bloodstream infection: a fatal case in a lung transplant recipient. Transpl Infect Dis 2005; 7: 146-9.
12. Odds FC, Van Nuffel L, Dams G. Prevalence of Candida dubliniensis isolates in a yeast stock collection. J Clin Microbiol 1998; 6: 2869-73.
13. Gilfillan G, Sullivan D, Haynes K, Parkinson T, Coleman DC, Gow NAR. Candida dubliniensis: phylogeny and putative virulence factors. Microbiology 1998; 144: 829-38.
14. Vilela MMS, Kamei JK, Sano A et al. Pathogenicity and virulence of Candida dubliniensis: comparison with C. albicans. Med Mycol 2002; 40: 249-57.
15. Arendrup M, Horn T, Frimodt-Moller N. In vivo pathogenicity of eight medically relevant Candida species in an animal model. Infection 2002; 30: 286-91.
16. Colombo AL, Guimarães T, Silva LR et al. Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality. Infect Control Hosp Epidemiol 2007; 28: 570-6.
17. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002; 50: 243-60.
18. Lagrou K, Verhaegen J, Peetermans WE, De Rijdt T, Maertens J, Van Wijingaerden E. Fungemia at a tertiary care hospital: incidence, therapy, and distribution and antifungal susceptibility of causative species. Eur J Clin Microbiol Infect Dis 2007; 26: 541-7.
19. Mosca CO, Moragues MD, Brena S, Rosa AC, Pontón J. Isolation of Candida dubliniensis in a teenager with denture stomatitis. Med Oral Patol Oral Cir Bucal 2005; 10: 28-31.
20. Ito CY, de Paiva Martins CA, Loberto JC, dos Santos SS, Jorge AO. In vitro antifungal susceptibility of Candida spp. isolates from patients with chronic periodontitis and from control patients. Braz Oral Res 2004; 18: 80-84.
21. Kwon-Chung KJ, Lehman D, Good C, Magee PT. Genetic evidence for role of extracellular proteinase in virulence of Candida albicans. Infect Immun 1985; 49: 571-5.
22. Parahitiyawa NB, Lin LJ, Leng WK, Yam WC, Samaranayake LP. Microbiolgy of odontogenic bacteremia: beyond endocarditis. Clin Microbiol Rev 2009; 22: 46-64.